Sign in

CIK 0001768224

  • Accelerated filer
  • Smaller reporting company

Arcturus Therapeutics Holdings Inc.

Sign in to watch
Ticker
ARCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 858-900-2660
Business address
10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
  1. 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $27.16 ($135,800)
  2. 4 Planned sale Chief Scientific Officer & COO sold 25,000 shares at an average $30.08 ($751,902)
  3. 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $25.93 ($129,650)
  4. 4 Open-market sale See Remarks sold 6,968 shares at $28.18 ($196,358)
  5. 4 Planned sale Chief Scientific Officer & COO sold 5,000 shares at $25.38 ($126,900)
  6. 4 Open-market sale Chief Scientific Officer & COO sold 5,000 shares at $16.07 ($80,350)
  7. 4 Open-market buy Director bought 2,222 shares at $18.00 ($39,996)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy President and CEO bought 5,000 shares at $16.51 ($82,550)
  16. 4 Grant or award Chief Financial Officer acquired 1,068 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 8 · 149 filings